Assessing Lantheus Holdings: Insights From 4 Financial Analysts

During the last three months, 4 analysts shared their evaluations of Lantheus Holdings LNTH, revealing diverse outlooks from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Lantheus Holdings, presenting an average target of $98.75, a high estimate of $100.00, and a low estimate of $95.00. A 12.61% drop is evident in the current average compared to the previous average price target of $113.00.

Deciphering Analyst Ratings: An In-Depth Analysis

The standing of Lantheus Holdings among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Lantheus Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.
• Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lantheus Holdings compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Lantheus Holdings's stock. This examination reveals shifts in analysts' expectations over time.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Lantheus Holdings's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Lantheus Holdings analyst ratings.

Delving into Lantheus Holdings's Background

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Lantheus Holdings: Delving into Financials

Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.

Revenue Growth: Over the 3 months period, Lantheus Holdings showcased positive performance, achieving a revenue growth rate of 33.71% as of 30 September, 2023. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Lantheus Holdings's net margin excels beyond industry benchmarks, reaching 41.24%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): Lantheus Holdings's ROE excels beyond industry benchmarks, reaching 21.09%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Lantheus Holdings's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 9.23%, the company showcases efficient use of assets and strong financial health.

Debt Management: Lantheus Holdings's debt-to-equity ratio stands notably higher than the industry average, reaching 0.88. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.

The Basics of Analyst Ratings

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.